Journal article

Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital

S Loi, AMM Haydon, J Shapiro, MA Schwarz, HG Schneider

INTERNAL MEDICINE JOURNAL | WILEY | Published : 2004

Abstract

BACKGROUND: Serum tumour markers (TM) are often measured in hospital patients. The reasons for their use and their benefits with regards to earlier cancer diagnosis and patient management are not known. AIMS: To identify the patterns of TM use in a tertiary hospital and to determine the usefulness and appropriateness of requests in this setting. METHODS: A cross-sectional, retrospective study of TM ordered over a 3-month period was conducted. Data were obtained from patient records. CA-125, CA 15-3, CA 19-9, carcinoembryonic antigen (CEA), and alpha-fetoprotein (AFP) were studied. Prostate specific antigen was not separately investigated. The reasons for ordering, usefulness and appropriaten..

View full abstract